U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06940895) titled 'Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans' on April 15.
Brief Summary: The purpose of this study is to demonstrate the safety and efficacy of Sirolimus 0.2% topical gel for patients with Acanthosis Nigricans
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Acanthosis Nigricans
Intervention:
DRUG: Sirolimus 0.2%
sirolimus 0.2% gel
Recruitment Status: RECRUITING
Sponsor: Narrows Institute for Biomedical Research
Published by HT Digital Content Services with permission from Health Daily Digest....